NYSE$IHS
IHS Holding · Q4 2024 earnings
Q4 2024 earnings · · Before market open · Investor relations
Briefing
IHS Holding reported Q4 2024 revenue of $1.71B, a net loss of $1.64B.
For Q4 2024, IHS Holding reported Revenue was $1.71B, net loss was $1.64B. Management discusses segment trends, liquidity, and outlook in the quarterly filing.
- Revenue $1.71B for Q4 2024.
- Net loss $1.64B.
- MD&A highlights operating priorities, liquidity, and sector risks.
Headline financials
Revenue & EPS history
IHS · Revenue · Quarterly
$1.71B
Revenue by segment
IHS · $467M total across 3 segments · Q1 2026
- Nigeria$285M—61.0%
- Sub-Saharan Africa (ex-Nigeria)$130M—27.9%
- Latin America (discontinued operations)$51.8M—11.1%
Forward guidance
Outlook emphasizes clinical milestones, liquidity runway, and operating expense discipline.
Tailwinds
- Pipeline progress and partnership economics.
- Cash supports near-term operating plans.
Headwinds
- Operating losses until commercial scale.
- Financing and trial outcomes affect funding costs.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 12 quarterly earnings reports · overlaid with Q4 2024
+4.3%
Avg return
Earnings day
+6.0%
Avg return
5 days after
+4.5%
Avg return
30 days after
69%
9 / 13 earnings
Positive
+24.6%
Q4 2022
Best reaction
-14.1%
Q2 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +1.4% | -0.1% | +0.5% | |
| Q3 2025 | +3.9% | -4.3% | +18.4% | |
| Q4 2024 | +13.3% | +34.3% | +26.3% | |
| Q2 2024 | +16.4% | +24.3% | +11.4% | |
| Q4 2023 | +13.1% | +21.1% | +40.6% | |
| Q3 2023 | -5.7% | -7.2% | -21.4% | |
| Q2 2023 | -12.0% | -15.1% | -38.8% | |
| Q1 2023 | -5.9% | -7.1% | +2.5% | |
| Q4 2022 | +24.6% | +23.4% | +32.1% | |
| Q3 2022 | +9.2% | +6.9% | -6.2% | |
| Q2 2022 | -14.1% | -13.8% | -21.1% | |
| Q1 2022 | +6.7% | +4.7% | -4.9% | |
| Q4 2021 | +5.1% | +11.4% | +18.7% | |
| Q3 2021 | — | — | — | |
| Q2 2021 | — | — | — | |
| Q1 2021 | — | — | — | |
| Q4 2020 | — | — | — | |
| Q3 2020 | — | — | — | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — | |
| Q4 2017 | — | — | — | |
| Q3 2017 | — | — | — | |
| Q2 2017 | — | — | — | |
| Q1 2017 | — | — | — | |
| Q4 2016 | — | — | — | |
| Q3 2016 | — | — | — | |
| Q2 2016 | — | — | — | |
| Q1 2016 | — | — | — | |
| Q4 2015 | — | — | — | |
| Q3 2015 | — | — | — | |
| Q2 2015 | — | — | — | |
| Q1 2015 | — | — | — | |
| Q4 2014 | — | — | — | |
| Q3 2014 | — | — | — | |
| Q2 2014 | — | — | — | |
| Q1 2014 | — | — | — | |
| Q4 2013 | — | — | — | |
| Q3 2013 | — | — | — | |
| Q2 2013 | — | — | — | |
| Q1 2013 | — | — | — | |
| Q4 2012 | — | — | — | |
| Q3 2012 | — | — | — | |
| Q2 2012 | — | — | — | |
| Q1 2012 | — | — | — | |
| Q4 2011 | — | — | — | |
| Q3 2011 | — | — | — | |
| Q2 2011 | — | — | — | |
| Q1 2011 | — | — | — | |
| Q4 2010 | — | — | — | |
| Q3 2010 | — | — | — | |
| Q2 2010 | — | — | — | |
| Q1 2009 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro